Potential Immunopathogenic Role of the Mucosa-Bone Marrow Axis in IgA Nephropathy: Insights From Animal Models

Seminars in Nephrology

Volumn 28, Issue 1, 2008, Pages 66-77

  Suzuki, Yusuke ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antigens; bone marrow; IgA immune complex; innate immunity; mucosa; polymeric IgA; tolerance

Indexed keywords

IMMUNOGLOBULIN A; NEPHRITOGENIC ANTIGEN;

ARTICLE; BONE MARROW; CELLULAR IMMUNITY; IMMUNE SYSTEM; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INNATE IMMUNITY; MEMORY CELL; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; BONE MARROW; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, IGA; IMMUNITY, NATURAL; IMMUNOGLOBULIN A; MICE; MUCOUS MEMBRANE;

EID: 38349195095     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2007.10.008     Document Type: Article

References (96)

1. Appel G.B., and Wadman M. The IgA nephropathy treatment dilemma. Kidney Int 69 (2006) 1939-1944
2. Barratt J., and Feehally J. IgA nephropathy. J Am Soc Nephrol 16 (2005) 2088-2097
3. Julian B.A., and Novk J. IgA nephropathy: up date. Curr Opin Nephrol Hypertens 13 (2004) 171-179
4. Berger L., and Hinglais N. Les depots intercapillarires d'IgA-IgG. J Urol Nephrol 74 (1968) 694-695
5. Barrat J., Feehally J., and Smith A.C. Pathogenesis of IgA nephropathy. Semin Nephrol 24 (2004) 197-217
6. Gómez-Guerrero C., Suzuki Y., and Egido J. The identification of IgA receptors in human mesangial cells: in the search for "Eldorado". Kidney Int 62 (2002) 715-717
7. Floege J., Burg M., and Kliem V. Recurrent IgA nephropathy after kidney transplantation: not a benign condition. Nephrol Dial Transplant 13 (1998) 1933-1935
8. Cuevas X., Lloveras J., Mir M., et al. Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation. Transplant Proc 19 (1987) 2208-2209
9. Sanfilippo F., Croker B.P., and Bollinger R.R. Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 33 (1982) 370-376
10. Layward L., Finnemore A.M., Allen A.C., et al. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin Immunol Immunopathol 69 (1993) 306-313
11. van den Wall Bake A.W., Beyer W.E., Evers-Schouten J.H., et al. Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies. J Clin Invest 84 (1989) 1070-1075
12. van den Wall Bake A.W., Daha M.R., Evers-Schouten J., et al. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA. Am J Kidney Dis 12 (1988) 410-414
13. Nicholls K.M., Fairley K.F., Dowling J.P., et al. The clinical course of mesangial IgA associated nephropathy in adults. QJM 53 (1984) 227-250
14. Feehally J., Beattie T.J., Brenchley P.E., et al. Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 30 (1986) 924-931
15. Xie Y., Chen X., Nishi S., et al. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int 65 (2004) 1135-1144
16. Suzuki Y., and Tomino Y. The mucosa-bone-marrow axis in IgA nephropathy. Contrib Nephrol 157 (2007) 70-79
17. van den Wall Bake A.W., Daha M.R., and van Es L.A. Immunopathogenetic aspects of IgA nephropathy. Nephrologie 10 (1989) 141-145
18. van Es L.A., van den Wall Bake A.W., Stad R.K., et al. Enigmas in the pathogenesis of IgA nephropathy. Contrib Nephrol 111 (1995) 169-176
19. Kunkel E.J., and Butcher E.C. Plasma-cell homing. Nat Rev Immunol 3 (2003) 822-829
20. Rifai A., Small P.A., Teague P.O., et al. Experimental IgA nephropathy. J Exp Med 150 (1979) 1161-1173
21. Rifai A., and Millard K. Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. Clin Exp Immunol 60 (1985) 363-368
22. Chen A., Wong S.S., and Rifai A. Glomerular immune deposits in experimental IgA nephropathy: a continuum of circulating and in situ formed immune complexes. Am J Pathol 130 (1988) 216-222
23. Isaacs K., Miller F., and Lane B. Experimental model for IgA nephropathy. Clin Immunol Immunopathol 20 (1981) 419-426
24. Isaacs K., and Miller F. Role of antigen size and charge in immune complex glomerulonephritis. I. Active induction of disease with dextran and its derivatives. Lab Invest 47 (1982) 198-205
25. Grossetête B., Launay P., Lehuen A., et al. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int 53 (1998) 1321-1335
26. Launay P., Grossetête B., Arcos-Fajardo M., et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 191 (1999) 1999-2009
27. Baldree L.A., Wyatt R.J., Julian B.A., et al. Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy. Am J Kidney Dis 22 (1993) 1-4
28. Zheng F., Kundu G.C., Zhang Z., et al. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med 5 (1999) 1018-1025
29. Zhang Q., and Mosher D.F. Cross-linking of the NH2-terminal region of fibronectin to molecules of large apparent molecular mass. Characterization of fibronectin assembly sites induced by the treatment of fibroblasts with lysophosphatidic acid. J Biol Chem 271 (1996) 33284-33292
30. Coppo R., Chiesa M., Cirina P., et al. In human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice. Am J Kidney Dis 40 (2002) 495-503
31. Hiki Y., Odani H., Takahashi M., et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59 (2001) 1077-1085
32. Allen A.C., Bailey E.M., Brenchley P.E., et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 60 (2001) 969-973
33. Tomana M., Novak J., Julian B.A., et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104 (1999) 73-81
34. Mestecky J., Suzuki H., Yanagihara T., et al. IgA nephropathy: current views of immune complex formation. Contrib Nephrol 157 (2007) 56-63
35. Hiki Y., Kokubo T., Iwase H., et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 10 (1999) 760-769
36. Mestecky J., Hashim O.H., and Tomana M. Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib Nephrol 111 (1995) 66-71
37. Muso E., Yoshida H., Takeuchi E., et al. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice. Kidney Int 50 (1996) 1946-1957
38. Muso E., Yoshida H., Takeuchi E., et al. Selective breeding for high serum IgA levels from noninbred ddY mice: isolation of a strain with an early onset of glomerular IgA deposition. Nephron 76 (1997) 201-207
39. Kobayashi I., Nogaki F., Kusano H., et al. Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. Nephrol Dial Transplant 17 (2002) 2108-2116
40. Marquina R., Díez M.A., López-Hoyos M., et al. Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice. J Immunol 172 (2004) 7177-7185
41. Nishie T., Miyaishi O., Azuma H., et al. Development of immunoglobulin A nephropathy-like disease in beta-1,4-galactosyltransferase-I-deficient mice. Am J Pathol 170 (2007) 447-456
42. Harper S.J., Allen A.C., Pringle J.H., et al. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 49 (1996) 38-42
43. Sakai O. IgA nephropathy: current concepts and feature trends. Nephrology 3 (1997) 2-3
44. Iwata Y., Wada T., Uchiyama A., et al. Remission of IgA nephropathy after allogeneic peripheral blood stem cell transplantation followed by immunosuppression for acute lymphocytic leukemia. Intern Med 45 (2006) 1291-1295
45. Imasawa T., Nagasawa R., Utsunomiya Y., et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int 56 (1999) 1809-1817
46. Imai H., Nakamoto Y., Asakura K., et al. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 27 (1985) 756-761
47. Suzuki H., Suzuki Y., Yamanaka T., et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J Am Soc Nephrol 16 (2005) 1289-1299
48. Gharavi A.G., Yan Y., Scolari F., et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26 (2000) 354-357
49. Suzuki H., Suzuki Y., Aizawa M., et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int 72 (2007) 319-327
50. Shinkura R., Kitada K., Matsuda F., et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat Genet 22 (1999) 74-77
51. Aizawa M., Suzuki Y., Suzuki H., et al. Bone marrow cells from IgA nephropathy model mice reconstitute glomerular IgA deposition, but not the disease progression, in alymphoplasia mutant mice. [abstract]. J Am Soc Nephrol 17 (2006) 352A
52. Sinniah R. Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 36 (1983) 276-279
53. Varis J., Rantala I., Pasternack A., et al. Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. J Clin Pathol 46 (1993) 607-610
54. Clarkson A.R., Woodroffe A.J., Bannister K.M., et al. The syndrome of IgA nephropathy. Clin Nephrol 21 (1984) 7-14
55. Nakamoto Y., Iida H., Kobayashi K., et al. Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Arch A Pathol Anat Histol 392 (1981) 45-54
56. Woodroffe A.J., Clarkson A.R., Seymour A.E., et al. Mesangial IgA nephritis. Springer Semin Immunopathol 5 (1982) 321-332
57. Moorthy A.V., Zimmerman S.W., and Maxim P.E. Dermatitis herpetiformis and celiac disease: association with glomerulonephritis, hypocomplementia, and circulating immune complexes. JAMA 239 (1978) 2019-2020
58. Katz A., Dyck R.F., and Bear R.A. Celiac disease associated with immune complex glomerulonephritis. Clin Nephrol 11 (1979) 39-44
59. Endo Y., and Hara M. Glomerular IgA deposition in pulmonary diseases. Kidney Int 29 (1986) 557-562
60. de Fijter J.W., Eijgenraam J.W., Braam C.A., et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 50 (1996) 952-961
61. Roodnat J.I., de Fijter J.W., van Kooten C., et al. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy. Nephrol Dial Transplant 14 (1999) 353-359
62. Layward L., Allen A.C., Hattersley J.M., et al. Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant 8 (1993) 25-28
63. Leinikki P.O., Mustonen J., and Pasternack A. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin Exp Immunol 68 (1987) 33-38
64. Emancipator S.N., Gallo G.R., and Lamm M.E. Experimental IgA nephropathy induced by oral immunization. J Exp Med 157 (1983) 572-582
65. Coppo R., Basolo B., Rollino C., et al. Mediterranean diet and primary IgA nephropathy. Clin Nephrol 26 (1986) 72-82
66. Kumar V., Sieniawska M., Beutner E.H., et al. Are immunological markers of gluten-sensitive enteropathy detectable in IgA nephropathy?. Lancet 2 (1988) 1307
67. Fornasieri A., Sinico R.A., Maldifassi P., et al. IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). BMJ 295 (1987) 78-80
68. Rostoker G., Laurent J., André C., et al. High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease. Lancet i (1988) 356-357
69. Coppo R., Mazzucco G., Martina G., et al. Gluten-induced experimental IgA glomerulopathy. Lab Invest 60 (1989) 499-506
70. Yan D., Rumbeiha W.K., and Pestka J.J. Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies. Food Chem Toxicol 36 (1998) 1095-1106
71. Pestka J.J. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol Lett 140-141 (2003) 287-295
72. Shi Y., and Pestka J.J. Attenuation of mycotoxin-induced IgA nephropathy by eicosapentaenoic acid in the mouse: dose response and relation to IL-6 expression. J Nutr Biochem 17 (2006) 697-706
73. Hinoshita F., Suzuki Y., Yokoyama K., et al. Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol. Nephron 75 (1997) 469-478
74. Koyama A., Kobayashi M., Yamaguchi N., et al. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int 47 (1995) 207-216
75. Muro K., Yamagata K., Kobayashi M., et al. Usage of T cell receptor variable segments of the beta-chain in IgA nephropathy. Nephron 92 (2002) 56-63
76. Koyama A., Sharmin S., Sakurai H., et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 66 (2004) 121-132
77. Sharmin S., Shimizu Y., Hagiwara M., et al. Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 17 (2004) 504-511
78. Yamamoto C., Suzuki S., Kimura H., et al. Experimental nephropathy induced by Haemophilus parainfluenzae antigens. Nephron 90 (2002) 320-327
79. Suzuki S., Nakatomi Y., Sato H., et al. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 343 (1994) 12-16
80. Suzuki S., Nakatomi Y., Odani S., et al. Circulating IgA, IgG, and IgM class antibody against Haemophilus parainfluenzae antigens in patients with IgA nephropathy. Clin Exp Immunol 104 (1996) 306-311
81. Porter D.D., Larsen A.E., and Porter H.G. Aleutian disease of mink. Adv Immunol 29 (1980) 261-286
82. Portis J.L., and Coe J.E. Deposition of IgA in renal glomeruli of mink affected with Aleutian disease. Am J Pathol 96 (1979) 227-236
83. Jessen R.H., Emancipator S.N., and Jacobs G.H. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status. Lab Invest 67 (1992) 379-386
84. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
85. Akira S., and Takeda K. Toll-like receptor signaling. Nat Rev Immunol 4 (2004) 499-511
86. Liu B., Yang Y., Dai J., et al. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol 177 (2006) 6880-6888
87. Brown H.J., Sacks S.H., and Robson M.G. Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol 17 (2006) 1931-1939
88. Suzuki H., Suzuki Y., Kano T., et al. Toll-like receptor 9 activation accelerates the progression of murine IgA nephropathy. [abstract]. J Am Soc Nephrol 16 (2005) 207A
89. Wills-Karp M., Santeliz J., and Karp C.L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1 (2001) 69-75
90. Johnson R.J., Hurtado A., Merszei J., et al. Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide. Am J Kidney Dis 42 (2003) 575-581
91. Hurtado A., and Johnson R.J. Hygiene hypothesis and prevalence of glomerulonephritis. Kidney Int Suppl 97 (2005) S62-S67
92. Gesualdo L., Lamm M.E., and Emancipator S.N. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145 (1990) 3684-3691
93. Gommerman J.L., and Browning J.L. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 3 (2003) 642-655
94. Wang J., and Fu Y.X. The role of LIGHT in T cell-mediated immunity. Immunol Res 30 (2004) 201-214
95. Wang J., Anders R.A., Wu Q., et al. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest 113 (2004) 826-835
96. Yamanaka T., Tamauchi H., Suzuki Y., et al. Glomerular IgA deposition through Th2-dominant mucosal immune responses. [abstract]. J Am Soc Nephrol 16 (2005) 210A